Cubist Systematic Strategies’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Cubist Systematic Strategies’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-55,884	Closed	-$1.19M	–	4284
2024 Q1	$1.19M	Sell	55,884 -11,586	-17%	-$139K	0.01%	2027
2023 Q4	$648K	Buy	67,470 +67,460	+674,600%	+$328K	﹤0.01%	2369
2023 Q3	$26	Sell	10 -90	-90%	-$289	﹤0.01%	3252
2023 Q2	$467	Buy	+100	New	+$432	﹤0.01%	3384
2022 Q4	–	Sell	-2,900	Closed	-$9K	–	4713
2022 Q3	$9K	Buy	+2,900	New	+$7.24K	﹤0.01%	4298

Cubist Systematic Strategies's FUSN Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 55,884 shares — an estimated $1.19M sold.

Cubist Systematic Strategies first reported a position in FUSN in Q3 2022 and held it in 5 quarters. The position peaked at $1.19M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Cubist Systematic Strategies reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 55,884 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.19M.
Cubist Systematic Strategies first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2022 and held it in 5 quarters.
Cubist Systematic Strategies's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.19M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.